What we do
Our Research and Development activities are focused on applied research and/or experimental development. They enable us to bring to market a range of pharmaceutical products aimed at treating the most relevant conditions affecting society, such as cardiovascular and metabolic diseases, nervous system disorders, and infectious diseases.
To this end, we rely on the areas of pharmaceutical chemistry, pharmaceutical development, cell culture, and clinical research to advance our Research and Development programmes and projects.
We have an experienced team with training in the areas of medicine, pharmacology, biology, biotechnology, microbiology, biochemistry, chemistry, and engineering for the design, implementation, and management of Research and Development activities.
For the last 20 years, as a result of our scientific and financial efforts, we have occupied a privileged place on the list of Portuguese companies that invest the most in Research and Development.
Our Pipeline
Pharmaceutical Technologies
In our Research & Development Unit, besides the more common technologies that we have in place to develop high quality pharmaceutical products, we also have available a set of highly valuable technologies to overcome drug solubility and bioavailability problems and for the development of specific pharmaceutical dosage forms.
Spray Drying, a technology with multiple applications, plays an important role in particle engineering to increase drug solubility and consequently its bioavailability being used in the development of oral solid dosage forms and other complex formulations.
Hot Melt Extrusion, a technology also used for solubility and bioavailability enhancement of BCS class 2 and 4 drugs. This technology has multiple applications being used in the development of IR and XR oral solid dosage forms and more complex formulations.
Projetos em curso
Conheça alguns dos projetos em curso de I&D do Grupo Tecnimede.
Featured Projects
Projetos co-financiados
Patents and Publications
One of the objectives of the Tecnimede Group is the dissemination of scientific knowledge obtained during the course of R&D programmes and projects by periodically patenting and publishing the results obtained. To date, the Tecnimede Group has over 440 patents (patents granted and patent applications) relating to new chemical entities, alternative synthesis processes, new salts, pharmaceutical compositions, and new therapeutic indications.